Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-20-019127

EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-07 Exercise or conversion : show line 1 in the form +1,250 15,201 D
2020-06-07 Shares withheld for taxes : show line 2 in the form −368 $17.19 $6,326 14,833 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-07 Exercise or conversion : show line 3 in the form Restricted Stock Unit Award −1,250 1,250 D
Loading xslF345X03/form4.xml…